© 2021 MJH Life Sciences and Cure Today. All rights reserved.
© 2021 MJH Life Sciences™ and Cure Today. All rights reserved.
November 11, 2017
Many patients who completed the survey felt maintenance therapy would help them buy time.
September 27, 2017
Expanding surveillance after surgery from chest X-ray to follow-up with PET-CT scan did not improve overall survival (OS), researchers reported during the 2017 ESMO Congress.
September 11, 2017
Keytruda (pembrolizumab) produced better overall survival (OS) rates than chemotherapy for patients with recurrent, advanced urothelial carcinoma.
February 07, 2017
Patients with certain types of sarcoma may benefit from PD-1 blockades, according to a recent study.
FDA’s Approval of Keytruda-Based Regimen for Certain Stomach Cancer Subtypes ‘Really Exciting’ For Patients
Heart Failure May Increase Cancer Risk
Easing Worried Patients During Difficult Times Throughout Cancer Treatment
A Trail of Crumbs